BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jansen C, Möller P, Meyer C, Kolbe CC, Bogs C, Pohlmann A, Schierwagen R, Praktiknjo M, Abdullah Z, Lehmann J, Thomas D, Strassburg CP, Latz E, Mueller S, Rössle M, Trebicka J. Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Hepatology 2018;67:1472-84. [PMID: 29059466 DOI: 10.1002/hep.29612] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Guo H, Zhang M, Zhang N, Yin X, Cheng Y, Gu L, Wang X, Xiao J, Wang Y, Zou X, Zhuge Y, Zhang F. Number of endoscopic sessions to eradicate varices identifies high risk of rebleeding in cirrhotic patients. BMC Gastroenterol 2022;22:213. [PMID: 35505293 DOI: 10.1186/s12876-022-02283-0] [Reference Citation Analysis]
2 Wang C, Liu J, Yao J, Ju S, Wang Y, Yang C, Bai Y, Yao W, Li T, Chen Y, Huang S, Xiong B. Transjugular intrahepatic portosystemic shunt in patients with autoimmune hepatitis-induced cirrhosis and variceal bleeding. Abdom Radiol (NY) 2022;47:1464-72. [PMID: 35230498 DOI: 10.1007/s00261-022-03465-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pan Y, Guo R, Lv Y, Cui D, Xie J, Ravaioli F. The Role of von Willebrand Factor Antigen in Predicting Survival of Patients with HBV-Related Cirrhosis. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-10. [DOI: 10.1155/2022/9035971] [Reference Citation Analysis]
4 Bucsics T, Lampichler K, Vierziger C, Schoder M, Wolf F, Bauer D, Simbrunner B, Hartl L, Jachs M, Scheiner B, Trauner M, Gruenberger T, Karnel F, Mandorfer M, Reiberger T. Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis. Dig Dis Sci 2022. [PMID: 35301618 DOI: 10.1007/s10620-022-07443-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Trebicka J, Gu W, de Ledinghen V, Aubé C, Krag A, Praktiknjo M, Castera L, Dumortier J, Bauer DJM, Friedrich-Rust M, Pol S, Grgurevic I, Zheng R, Francque S, Gottfriedovà H, Mustapic S, Sporea I, Berzigotti A, Uschner FE, Simbrunner B, Ronot M, Cassinotto C, Kjaergaard M, Andrade F, Schulz M, Semmler G, Drinkovic IT, Chang J, Brol MJ, Rautou PE, Vanwolleghem T, Strassburg CP, Boursier J, Ferstl PG, Rasmussen DN, Reiberger T, Vilgrain V, Guibal A, Guillaud O, Zeuzem S, Vassord C, Lu X, Vonghia L, Senkerikova R, Popescu A, Margini C, Wang W, Thiele M, Jansen C. Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease. Gut 2022;71:402-14. [PMID: 33479052 DOI: 10.1136/gutjnl-2020-323419] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
6 Reiberger T. The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis. Hepatol Commun 2021. [PMID: 34904404 DOI: 10.1002/hep4.1855] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
7 Han H, Yang J, Jin WK, Li X, Zhang F, Zhuge YZ, Wu M, Yang B. Diagnostic value of conventional ultrasound and shear wave elastography in detecting transjugular intrahepatic portosystemic shunt dysfunction. Acta Radiol 2021;62:1575-82. [PMID: 33251812 DOI: 10.1177/0284185120975183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Praktiknjo M, Schierwagen R, Monteiro S, Ortiz C, Uschner FE, Jansen C, Claria J, Trebicka J. Hepatic inflammasome activation as origin of Interleukin-1α and Interleukin-1β in liver cirrhosis. Gut 2021;70:1799-800. [PMID: 33087491 DOI: 10.1136/gutjnl-2020-322621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Yu J, Shi X, Ma J, Chen R, Dong S, Lu S, Wu J, Yan C, Wu J, Zheng S, Li L, Xu X, Cao H. C-Reactive Protein Is an Independent Predictor of 30-Day Bacterial Infection Post-Liver Transplantation. Biomolecules 2021;11:1195. [PMID: 34439862 DOI: 10.3390/biom11081195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhang Y, Chen H, Chen S, Li W. Prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma (HCC) treated by radiofrequency ablation: a meta-analysis. Int J Hyperthermia 2021;38:1052-9. [PMID: 34251953 DOI: 10.1080/02656736.2021.1947529] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu., Clinical Practice Guideline Panel., Chair:., EASL Governing Board representative:., Panel members:. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol 2021;75:659-89. [PMID: 34166721 DOI: 10.1016/j.jhep.2021.05.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 125] [Article Influence: 16.0] [Reference Citation Analysis]
12 Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy. JHEP Rep 2021;3:100316. [PMID: 34337369 DOI: 10.1016/j.jhepr.2021.100316] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
13 Wolter K, Praktiknjo M, Boie J, Decker G, Nadal J, Jansen C, Keller WIY, Meyer C, Trebicka J, Attenberger U, Thomas D. Glue Embolization of Gastroesophageal Varices during Transjugular Intrahepatic Portosystemic Shunt (TIPS) Improves Survival Compared to Coil-only Embolization-A Single-Center Retrospective Study. Cardiovasc Intervent Radiol 2021;44:1240-50. [PMID: 34021379 DOI: 10.1007/s00270-021-02852-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Piecha F, Gänßler JM, Ozga AK, Wehmeyer MH, Kluwe J, Lampalzer S, Creutzfeldt AM, Buescher G, Horvatits T, Sterneck M, Pischke S, Lohse AW, Schulze Zur Wiesch J. Evolution of liver stiffness and post-treatment surveillance by liver elastography for HCV patients in the DAA era. Scand J Gastroenterol 2021;56:840-8. [PMID: 34010581 DOI: 10.1080/00365521.2021.1915374] [Reference Citation Analysis]
15 Natarajan V, Moeun Y, Kidambi S. Exploring Interactions between Primary Hepatocytes and Non-Parenchymal Cells on Physiological and Pathological Liver Stiffness. Biology (Basel) 2021;10:408. [PMID: 34063016 DOI: 10.3390/biology10050408] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Dajti E, Marasco G, Ravaioli F, Alemanni LV, Rossini B, Colecchia L, Vestito A, Festi D, Colecchia A. The role of liver and spleen elastography in advanced chronic liver disease. Minerva Gastroenterol (Torino) 2021;67:151-63. [PMID: 34027932 DOI: 10.23736/S2724-5985.20.02793-2] [Reference Citation Analysis]
17 Zhou H, Zhang Z, Zhang J, Sang L, Liu L, Lv Y, Gong X, Yin Z, Sun Y, Han G, Yu M. Spleen Stiffness Performance in the Noninvasive Assessment of Gastroesophageal Varices after Transjugular Intrahepatic Portosystemic Shunts. Biomed Res Int 2021;2021:5530004. [PMID: 33959657 DOI: 10.1155/2021/5530004] [Reference Citation Analysis]
18 Dajti E, Alemanni LV, Marasco G, Montagnani M, Azzaroli F. Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests? Hepat Med 2021;13:25-36. [PMID: 33776492 DOI: 10.2147/HMER.S278077] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Trebicka J, Sundaram V, Moreau R, Jalan R, Arroyo V. Liver Transplantation for Acute-on-Chronic Liver Failure: Science or Fiction? Liver Transpl. 2020;26:906-915. [PMID: 32365422 DOI: 10.1002/lt.25788] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
20 Monteiro S, Grandt J, Uschner FE, Kimer N, Madsen JL, Schierwagen R, Klein S, Welsch C, Schäfer L, Jansen C, Claria J, Alcaraz-Quiles J, Arroyo V, Moreau R, Fernandez J, Bendtsen F, Mehta G, Gluud LL, Møller S, Praktiknjo M, Trebicka J. Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation. Gut 2021;70:379-87. [PMID: 32241903 DOI: 10.1136/gutjnl-2019-320170] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
21 Seifert LL, Görlich D, Jansen C, Ortmann O, Schoster M, Praktiknjo M, Gu W, Schindler P, Köhler M, Maschmeier M, Wilms C, Meyer C, Schmidt HH, Wildgruber M, Trebicka J, Heinzow H. Evaluation of impact of elective invasive examinations in patients with transjugular intrahepatic portosystemic shunt in the long-term follow up. Z Gastroenterol 2021;59:24-34. [PMID: 33429447 DOI: 10.1055/a-1330-9867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Janik MK, Kruk B, Szczepankiewicz B, Kostrzewa K, Raszeja-Wyszomirska J, Górnicka B, Lammert F, Milkiewicz P, Krawczyk M. Measurement of liver and spleen stiffness as complementary methods for assessment of liver fibrosis in autoimmune hepatitis. Liver Int 2021;41:348-56. [PMID: 33159831 DOI: 10.1111/liv.14726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
23 Trebicka J, Bork P, Krag A, Arumugam M. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure. Nat Rev Gastroenterol Hepatol 2021;18:167-80. [PMID: 33257833 DOI: 10.1038/s41575-020-00376-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 17.0] [Reference Citation Analysis]
24 Zhu H, Guo H, Yin X, Yang J, Yin Q, Xiao J, Wang Y, Zhang M, Han H, Zhuge Y, Zhang F. Spleen Stiffness Predicts Survival after Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients. Biomed Res Int 2020;2020:3860390. [PMID: 33282945 DOI: 10.1155/2020/3860390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Kennedy P, Bane O, Hectors SJ, Fischman A, Schiano T, Lewis S, Taouli B. Noninvasive imaging assessment of portal hypertension. Abdom Radiol (NY) 2020;45:3473-95. [PMID: 32926209 DOI: 10.1007/s00261-020-02729-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
26 Schierwagen R, Uschner FE, Ortiz C, Torres S, Brol MJ, Tyc O, Gu W, Grimm C, Zeuzem S, Plamper A, Pfeifer P, Zimmer S, Welsch C, Schaefer L, Rheinwalt KP, Clària J, Arroyo V, Trebicka J, Klein S. The Role of Macrophage-Inducible C-Type Lectin in Different Stages of Chronic Liver Disease. Front Immunol 2020;11:1352. [PMID: 32733451 DOI: 10.3389/fimmu.2020.01352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
27 Mandorfer M, Hernández-Gea V, García-Pagán JC, Reiberger T. Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review. Semin Liver Dis 2020;40:240-55. [PMID: 32557480 DOI: 10.1055/s-0040-1708806] [Cited by in Crossref: 10] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
28 Barr RG, Wilson SR, Rubens D, Garcia-Tsao G, Ferraioli G. Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement. Radiology. 2020;296:263-274. [PMID: 32515681 DOI: 10.1148/radiol.2020192437] [Cited by in Crossref: 26] [Cited by in F6Publishing: 66] [Article Influence: 13.0] [Reference Citation Analysis]
29 Bernardi M, Angeli P, Claria J, Moreau R, Gines P, Jalan R, Caraceni P, Fernandez J, Gerbes AL, O'Brien AJ, Trebicka J, Thevenot T, Arroyo V. Albumin in decompensated cirrhosis: new concepts and perspectives. Gut 2020;69:1127-38. [PMID: 32102926 DOI: 10.1136/gutjnl-2019-318843] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 36.0] [Reference Citation Analysis]
30 Serra JT, Mueller J, Teng H, Elshaarawy O, Mueller S. Prospective Comparison of Transient Elastography Using Two Different Devices: Performance of FibroScan and FibroTouch. Hepat Med 2020;12:41-8. [PMID: 32280285 DOI: 10.2147/HMER.S245455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
31 Queck A, Bode H, Uschner FE, Brol MJ, Graf C, Schulz M, Jansen C, Praktiknjo M, Schierwagen R, Klein S, Trautwein C, Wasmuth HE, Berres ML, Trebicka J, Lehmann J. Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis. Front Immunol 2020;11:354. [PMID: 32218781 DOI: 10.3389/fimmu.2020.00354] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
32 Maurice J, Pinzani M. The stratification of cirrhosis. Hepatol Res 2020;50:535-41. [PMID: 32072721 DOI: 10.1111/hepr.13493] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
33 Lee PC, Chiou YY, Chiu NC, Chen PH, Liu CA, Kao WY, Huo TI, Huang YH, Hou MC, Lin HC, Wu JC, Su CW. Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation. Sci Rep 2020;10:2006. [PMID: 32029840 DOI: 10.1038/s41598-020-58988-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Klein LM, Chang J, Gu W, Manekeller S, Jansen C, Lingohr P, Praktiknjo M, Kalf JC, Schulz M, Spengler U, Strassburg C, Cárdenas A, Arroyo V, Trebicka J. The Development and Outcome of Acute-on-Chronic Liver Failure After Surgical Interventions. Liver Transpl 2020;26:227-37. [PMID: 31693788 DOI: 10.1002/lt.25675] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
35 Piecha F, Radunski UK, Ozga AK, Steins D, Drolz A, Horvatits T, Spink C, Ittrich H, Benten D, Lohse AW, Sinning C, Kluwe J. Ascites control by TIPS is more successful in patients with a lower paracentesis frequency and is associated with improved survival. JHEP Rep. 2019;1:90-98. [PMID: 32039356 DOI: 10.1016/j.jhepr.2019.04.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
36 Mandorfer M, Hernández-gea V, Reiberger T, García-pagán JC. Hepatic Venous Pressure Gradient Response in Non-Selective Beta-Blocker Treatment—Is It Worth Measuring? Curr Hepatology Rep 2019;18:174-86. [DOI: 10.1007/s11901-019-00469-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
37 Praktiknjo M, Djayadi N, Mohr R, Schierwagen R, Bischoff J, Dold L, Pohlmann A, Schwarze-Zander C, Wasmuth JC, Boesecke C, Rockstroh JK, Trebicka J. Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non-obese HIV-infected patients. Liver Int. 2019;39:1514-1520. [PMID: 30916873 DOI: 10.1111/liv.14107] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
38 Trebicka J, Amoros A, Pitarch C, Titos E, Alcaraz-Quiles J, Schierwagen R, Deulofeu C, Fernandez-Gomez J, Piano S, Caraceni P, Oettl K, Sola E, Laleman W, McNaughtan J, Mookerjee RP, Coenraad MJ, Welzel T, Steib C, Garcia R, Gustot T, Rodriguez Gandia MA, Bañares R, Albillos A, Zeuzem S, Vargas V, Saliba F, Nevens F, Alessandria C, de Gottardi A, Zoller H, Ginès P, Sauerbruch T, Gerbes A, Stauber RE, Bernardi M, Angeli P, Pavesi M, Moreau R, Clària J, Jalan R, Arroyo V. Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis. Front Immunol 2019;10:476. [PMID: 30941129 DOI: 10.3389/fimmu.2019.00476] [Cited by in Crossref: 55] [Cited by in F6Publishing: 68] [Article Influence: 18.3] [Reference Citation Analysis]
39 Schierwagen R, Alvarez-Silva C, Madsen MSA, Kolbe CC, Meyer C, Thomas D, Uschner FE, Magdaleno F, Jansen C, Pohlmann A, Praktiknjo M, Hischebeth GT, Molitor E, Latz E, Lelouvier B, Trebicka J, Arumugam M. Circulating microbiome in blood of different circulatory compartments. Gut 2019;68:578-80. [PMID: 29581241 DOI: 10.1136/gutjnl-2018-316227] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 25.0] [Reference Citation Analysis]
40 Attia D, Rodt T, Marquardt S, Hinrichs J, Meyer BC, Gebel M, Wacker F, Manns MP, Potthoff A. Shear wave elastography prior to transjugular intrahepatic portosystemic shunt may predict the decrease in hepatic vein pressure gradient. Abdom Radiol (NY) 2019;44:1127-34. [PMID: 30288582 DOI: 10.1007/s00261-018-1795-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
41 Elmahdy AM, Berzigotti A. Non-invasive Measurement of Portal Pressure. Curr Hepatology Rep 2019;18:20-7. [DOI: 10.1007/s11901-019-00446-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Moreno C, Mueller S, Szabo G. Non-invasive diagnosis and biomarkers in alcohol-related liver disease. Journal of Hepatology 2019;70:273-83. [DOI: 10.1016/j.jhep.2018.11.025] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 16.0] [Reference Citation Analysis]
43 Piecha F, Mandorfer M, Peccerella T, Ozga A, Poth T, Vonbank A, Seitz HK, Rausch V, Reiberger T, Mueller S. Pharmacological decrease of liver stiffness is pressure-related and predicts long-term clinical outcome. American Journal of Physiology-Gastrointestinal and Liver Physiology 2018;315:G484-94. [DOI: 10.1152/ajpgi.00392.2017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 6.8] [Reference Citation Analysis]
44 Trebicka J, Reiberger T, Laleman W. Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure. Visc Med. 2018;34:270-275. [PMID: 30345284 DOI: 10.1159/000490262] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
45 Sauerbruch T, Schierwagen R, Trebicka J. Managing portal hypertension in patients with liver cirrhosis. F1000Res 2018;7:F1000 Faculty Rev-533. [PMID: 29780579 DOI: 10.12688/f1000research.13943.1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
46 Schepis F, Vizzutti F, Garcia-Tsao G, Marzocchi G, Rega L, De Maria N, Di Maira T, Gitto S, Caporali C, Colopi S, De Santis M, Arena U, Rampoldi A, Airoldi A, Cannavale A, Fanelli F, Mosconi C, Renzulli M, Agazzi R, Nani R, Quaretti P, Fiorina I, Moramarco L, Miraglia R, Luca A, Bruno R, Fagiuoli S, Golfieri R, Torricelli P, Di Benedetto F, Belli LS, Banchelli F, Laffi G, Marra F, Villa E. Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2018;16:1153-1162.e7. [PMID: 29378312 DOI: 10.1016/j.cgh.2018.01.029] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 13.8] [Reference Citation Analysis]
47 Berzigotti A. Advances and challenges in cirrhosis and portal hypertension. BMC Med. 2017;15:200. [PMID: 29121925 DOI: 10.1186/s12916-017-0966-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]